These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 36581167)
1. Cell death regulation: A new way for natural products to treat osteoporosis. Li Z; Li D; Chen R; Gao S; Xu Z; Li N Pharmacol Res; 2023 Jan; 187():106635. PubMed ID: 36581167 [TBL] [Abstract][Full Text] [Related]
2. Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation. An J; Yang H; Zhang Q; Liu C; Zhao J; Zhang L; Chen B Life Sci; 2016 Feb; 147():46-58. PubMed ID: 26796578 [TBL] [Abstract][Full Text] [Related]
3. Exploring natural products-based cancer therapeutics derived from egyptian flora. El-Seedi HR; Yosri N; Khalifa SAM; Guo Z; Musharraf SG; Xiao J; Saeed A; Du M; Khatib A; Abdel-Daim MM; Efferth T; Göransson U; Verpoorte R J Ethnopharmacol; 2021 Apr; 269():113626. PubMed ID: 33248183 [TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery. Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315 [TBL] [Abstract][Full Text] [Related]
5. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Wang L; Waltenberger B; Pferschy-Wenzig EM; Blunder M; Liu X; Malainer C; Blazevic T; Schwaiger S; Rollinger JM; Heiss EH; Schuster D; Kopp B; Bauer R; Stuppner H; Dirsch VM; Atanasov AG Biochem Pharmacol; 2014 Nov; 92(1):73-89. PubMed ID: 25083916 [TBL] [Abstract][Full Text] [Related]
6. Eurycoma longifolia as a potential alternative to testosterone for the treatment of osteoporosis: Exploring time-mannered proliferative, differentiative and morphogenic modulation in osteoblasts. Thu HE; Mohamed IN; Hussain Z; Shuid AN J Ethnopharmacol; 2017 Jan; 195():143-158. PubMed ID: 27818256 [TBL] [Abstract][Full Text] [Related]
7. Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches. Cai K; Jiang H; Zou Y; Song C; Cao K; Chen S; Wu Y; Zhang Z; Geng D; Zhang N; Liu B; Sun G; Tang M; Li Z; Zhang Y; Sun Y; Zhang Y Pharmacol Res; 2024 Aug; 206():107281. PubMed ID: 38942341 [TBL] [Abstract][Full Text] [Related]
8. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy. Rajagopal C; Lankadasari MB; Aranjani JM; Harikumar KB Pharmacol Res; 2018 Apr; 130():273-291. PubMed ID: 29305909 [TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Effect of Natural Compounds on Osteoporosis through Ferroptosis. Zhang Y; Qu Z; Zhao Y; Zhang B; Gong Y; Wang X; Gao X; Wang D; Yan L Curr Med Chem; 2024; 31(18):2629-2648. PubMed ID: 37817519 [TBL] [Abstract][Full Text] [Related]
10. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease. Sahoo AK; Dandapat J; Dash UC; Kanhar S J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451 [TBL] [Abstract][Full Text] [Related]
11. Progress in the treatment of drug-induced liver injury with natural products. Sun YK; Zhang YF; Xie L; Rong F; Zhu XY; Xie J; Zhou H; Xu T Pharmacol Res; 2022 Sep; 183():106361. PubMed ID: 35882295 [TBL] [Abstract][Full Text] [Related]
12. Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis. Zhao X; Patil S; Xu F; Lin X; Qian A Biomolecules; 2021 May; 11(5):. PubMed ID: 34067783 [TBL] [Abstract][Full Text] [Related]
13. Natural products as drugs and tools for influencing core processes of eukaryotic mRNA translation. Burgers LD; Fürst R Pharmacol Res; 2021 Aug; 170():105535. PubMed ID: 34058326 [TBL] [Abstract][Full Text] [Related]
14. Natural medicines for the treatment of fatigue: Bioactive components, pharmacology, and mechanisms. Luo C; Xu X; Wei X; Feng W; Huang H; Liu H; Xu R; Lin J; Han L; Zhang D Pharmacol Res; 2019 Oct; 148():104409. PubMed ID: 31446039 [TBL] [Abstract][Full Text] [Related]
15. The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective. Rao T; Tan Z; Peng J; Guo Y; Chen Y; Zhou H; Ouyang D Pharmacol Res; 2019 Aug; 146():104283. PubMed ID: 31129178 [TBL] [Abstract][Full Text] [Related]
16. Diarylheptanoid from Curcuma comosa Roxb. suppresses RANKL-induced osteoclast differentiation by decreasing NFATc1 and c-Fos expression via MAPK pathway. Chawalitpong S; Sornkaew N; Suksamrarn A; Palaga T Eur J Pharmacol; 2016 Oct; 788():351-359. PubMed ID: 27523282 [TBL] [Abstract][Full Text] [Related]
17. Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins. Loukas AT; Papadourakis M; Panagiotopoulos V; Zarmpala A; Chontzopoulou E; Christodoulou S; Katsila T; Zoumpoulakis P; Matsoukas MT Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732267 [TBL] [Abstract][Full Text] [Related]
18. Potentially active compounds that improve PAD through angiogenesis: A review. Liu ZB; Fan XY; Wang CW; Ye X; Wu CJ Biomed Pharmacother; 2023 Dec; 168():115634. PubMed ID: 37879211 [TBL] [Abstract][Full Text] [Related]
19. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling. Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736 [TBL] [Abstract][Full Text] [Related]
20. Autophagy modulators from traditional Chinese medicine: Mechanisms and therapeutic potentials for cancer and neurodegenerative diseases. Wang SF; Wu MY; Cai CZ; Li M; Lu JH J Ethnopharmacol; 2016 Dec; 194():861-876. PubMed ID: 27793785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]